What Is The Definition Of The Global Dengue Vaccine Market?
A dengue vaccine is a biological preparation designed to prevent dengue fever, a mosquito-borne viral disease caused by the dengue virus (DENV). If exposed in the future, dengue vaccines stimulate the body's immune system to recognize and fight off the dengue virus.
Dengue Vaccine Global Market Report 2024 provides data on the global dengue vaccine market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The dengue vaccine market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.
How Is The Market Size And Growth Rate Of The Global Dengue Vaccine Market Projected?
The dengue vaccine market has expanded rapidly in recent years, from $0.57 billion in 2023 to $0.64 billion in 2024, at a CAGR of 12.0%. Growth has been driven by factors such as increased travel and urbanization, rising demand for effective vaccines, more frequent foreign travel exposure, expanded healthcare services, and mass vaccination efforts. The market is expected to continue growing, reaching $1.02 billion by 2028, at a CAGR of 12.3%. Contributing factors include the rising incidence of dengue, increasing clinical trials, initiatives by various organizations, and a focus on developing multi-strain and tetravalent vaccines. Trends in the forecast period include demand for preventative vaccines, advances in vaccine technology, combination vaccines, and a focus on improving vaccine efficacy and safety.
What Are The Primary Growth Drivers In The Dengue Vaccine Market?
The rising incidence of dengue fever is anticipated to bolster the dengue vaccine market. This viral infection, spread by Aedes aegypti mosquitoes, is driven by factors such as climate change, urbanization, inadequate mosquito control, and viral evolution. Dengue vaccines activate the immune system to fight the virus, reducing infection severity and hospitalization rates. For example, in May 2024, the World Health Organization reported over 7 million dengue cases in the Americas by April 2024, up from 4.6 million cases in 2023. This trend is expected to fuel growth in the dengue vaccine market.
Get Your Free Sample of the Global Dengue Vaccine Market Report
What Is The Segmentation Of The Global Dengue Vaccine Market?
The dengue vaccine market covered in this report is segmented –
1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine
2) By Vaccine Phase: Phase I, Phase II, Phase III
3) By Treatment: Diuretic, Anti-Allergic, Blood Thinners, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users
What Emerging Trends Are Shaping The Dengue Vaccine Market Landscape?
In the dengue vaccine market, leading companies are focusing on advanced vaccine formulations, such as the dengue tetravalent vaccine, to provide comprehensive protection against all four dengue virus serotypes in a single dose. The tetravalent vaccine protects against dengue virus types DEN-1, DEN-2, DEN-3, and DEN-4. For instance, in December 2022, Takeda Pharmaceutical Company, a Japanese pharmaceutical giant, secured European Commission approval for QDENGA, a live-attenuated vaccine for individuals aged four and older. Administered in two 0.5 mL doses three months apart, the vaccine has shown about 80.2% efficacy in preventing dengue and reducing hospitalizations. Clinical trials demonstrate that its protection lasts approximately 4.5 years, offering a longer-lasting solution compared to existing vaccines.
Which Region Has The Fastest Expansion In The Dengue Vaccine Market?
Asia-Pacific was the largest region in the dengue vaccine market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
